Electrostatically driven supramolecular drug-carrier system for targeted, efficient, safer Cancer chemotherapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Developing efficient and safe chemotherapy delivery systems is crucial for cancer treatment.
• Nanocarriers offer potential for targeted drug delivery and reduced systemic toxicity.
• Chitosan-based materials are biocompatible and versatile for biomedical applications.

Purpose of the Study:

• To demonstrate a new concept of complementary electrostatic interactions between drugs and nanocarriers.
• To develop a facile strategy for creating efficient, multifunctional drug delivery systems.
• To evaluate the potential for safer and more effective chemotherapy.

Main Methods:

• Co-assembly of water-soluble modified chitosan (Na-CMC) with positively charged anticancer agents (rhodamine 6G or doxorubicin).
• Formation of nanogels through electrostatic interactions in aqueous environments.
• Characterization of nanogel properties (loading capacity, morphology, stability, pH-responsiveness) and cellular studies (internalization, drug release, apoptosis induction).

Main Results:

• Na-CMC and R6G/DOX formed stable nanogels via electrostatic interactions.
• Na-CMC/R6G nanogels exhibited high drug loading, uniform size, stability, and pH-triggered release.
• Na-CMC/R6G nanogels were selectively internalized by HeLa cells, inducing targeted apoptosis.
• Na-CMC/DOX nanogels showed aggregation and induced non-specific cell death.

Conclusions:

• Complementary electrostatic interactions provide a promising strategy for designing effective nanocarrier-based drug delivery systems.
• Na-CMC/R6G nanogels demonstrate selective cancer cell internalization and targeted apoptosis induction.
• The choice of drug and carrier interaction is critical for achieving desired therapeutic outcomes and minimizing toxicity.